MRMaría José Ruiz-Olgado

María José Ruiz-Olgado

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


María José Ruiz-Olgado has a total of 69 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Natural Missplicing Events Amplified by an Elusive Deep-Intronic MYBPC3 Variant Cause Hypertrophic Cardiomyopathy

    by María Gallego-Delgado, Sandra Milagros Lorenzo Hernández, Soledad García Hernández, Sara Rodríguez-Diego, David Hansoe Heredero-Jung, Emilia Maneiro Pampín, Marlene Pérez-Barbeito, Mónica García Monsalvo, Belén García-Berrocal, Luis M. Rincón, et al.

    BACKGROUND: Disruption of MYBPC3 precursor mRNA splicing is a frequent genetic cause of hypertrophic cardiomyopathy (HCM). Most often, it reflects changes at canonical sites or the creation of novel splice sites. Prediction tools usually prioritize splice variants with lower efficiency when they are distant from canonical sites. These elusive variants may explain HCM in patients considered genotype-negative after DNA testing. METHODS: Massively parallel sequencing identified the previously unreported deep-intronic variant MYBPC3 c.2308+227G>A in a cohort of genotype-negative patients with HCM from Salamanca, Spain. SpliceAI predicted a benign effect (Δ score, 0.03). However, its recurrent detection prompted us to conduct extensive analyses to investigate its pathogenicity, including genetic testing, clinical assessment, family studies, splicing assays, and haplotype reconstruction. RESULTS: We identified 35 unrelated HCM probands carrying c.2308+227G>A, plus 46 relatives from 27 families, yielding 81 confirmed carriers. Of these, 56 (69%) met diagnostic criteria for HCM (66% male; mean age, 53±15 years). By age 60 years, cumulative penetrance was estimated to be 81% in women and 96% in men. The combined logarithm of the odds score of 5.51 across 20 informative families provided strong evidence of cosegregation. During follow-up of probands, no significant differences were observed in heart failure, arrhythmic events, atrial fibrillation, or mortality when compared with cohorts carrying other pathogenic MYBPC3 variants. Blood splicing assays, confirmed in cardiac tissue, showed that c.2308+227G>A disrupts splicing by the use of pre-existing cryptic donor (c.2308+299) and acceptor (c.2309−580) splice sites, generating 2 misspliced mRNAs with partial intron retention or cryptic exon inclusion, which encode truncated proteins. These cryptic sites are the leading natural, unannotated missplicing events in intron 23, and some of the most frequent across the whole MYBPC3 precursor mRNA, as revealed by SpliceVault analysis of RNA sequencing databases. This deep-intronic variant does not alter essential splice motifs but promotes the use of pre-existing cryptic sites, likely through gain of splicing regulatory enhancer elements. The identification of a shared haplotype among HCM probands carrying this variant explains its recurrent detection, consistent with an ancient founder effect. CONCLUSIONS: MYBPC3 c.2308+227G>A is a pathogenic splice-altering variant that causes HCM by amplifying natural missplicing events. These background splicing errors help explain how this elusive variant disrupts splicing without creating novel essential splice sites, thereby expanding the known mechanisms by which deep-intronic variants alter MYBPC3 splicing and ultimately contribute to HCM pathogenesis. Elusive MYBPC3 splice-altering variants should be considered in HCM patients with an unresolved genetic origin of disease.

  • Open Access

    Associations Between Chocolate Consumption and Cardiometabolic Risk Markers Across Metabolic Profiles: Insights from a Population-Based Study

    by Beatriz Martín-Carro, Estefanía Iglesias-Colino, Darian Montes-Riesgo, Sara Cascón, Leticia Nieto-García, Alfonso Romero, Pablo Pérez-Sánchez, Antonio Sánchez-Puente, Irene Varas-Marcos, Baltasara Blázquez, et al.

    Background/Objectives: Studies evaluating the association between chocolate consumption and cardiometabolic health have reported inconsistent findings, and whether these associations differ according to underlying metabolic status remains unclear. This cross-sectional study analysed whether metabolic profile modifies the associations between chocolate consumption and cardiometabolic risk markers in 1960 adults from the SALMANTICOR population-based cohort. Methods: Chocolate consumption was classified by chocolate type (dark or milk) and frequency of intake (occasional: 1–3 days/week; regular: ≥4 days/week). Multivariable linear regression models were used to evaluate associations with fasting glucose, glycated haemoglobin (HbA1c), high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, triglycerides, body mass index (BMI), waist circumference, and systolic blood pressure (SBP), with additional interaction analyses for diabetes, hypertension, and dyslipidaemia. Models were adjusted for age, sex, BMI (except when BMI was the outcome), smoking, alcohol consumption, physical activity, olive oil intake, and commercial pastry consumption. Results: Overall, 30.1% of participants reported habitual chocolate consumption. In multivariable models without interaction terms, both dark and milk chocolate consumption were associated with lower BMI, whereas dark chocolate consumption was associated with higher LDL cholesterol. After Bonferroni correction for multiple comparisons, diabetes modified the associations of dark chocolate consumption with fasting glucose and HbA1c and of milk chocolate consumption with HbA1c. Among individuals with diabetes, dark chocolate consumption was associated with lower fasting glucose and HbA1c, whereas milk chocolate consumption was associated with lower HbA1c compared with non-consumption. No such associations were observed among individuals without diabetes. Conclusions: These findings suggest that the association between chocolate consumption and cardiometabolic health is not uniform across the population but differs according to the underlying metabolic profile. In particular, the associations with glycaemic markers were confined to individuals with diabetes, suggesting that metabolic status may modify the relationship between habitual chocolate consumption and glycaemic control. Further prospective population-based studies and intervention trials are needed to confirm these findings.

  • Open Access

    Prognostic Factors of Acute Heart Failure: A Regional Population Registry

    by Juan Asensio-Nogueira, Miguel Rodriguez-Santamarta, Javier Tobar-Ruíz, Pedro Daniel Perdiguero-Martín, Inés Toranzo-Nieto, Clea González-Maniega, Adrián Lozano-Ibáñez, Lucía Moreno-De-Redrojo Cortes, Manuel Carrasco-Moraleja, Álvaro Margalejo-Franco, et al.

    Introduction and objectives: Acute heart failure (AHF) is the leading cardiovascular cause of hospitalization and remains associated with high mortality and rehospitalization rates. Contemporary real-world data from cardiology departments are scarce. We aimed to identify admission characteristics associated with one-year outcomes in patients hospitalized with AHF. Methods: RECYLICA is a prospective, multicentre, regional registry including consecutive patients admitted with AHF to cardiology departments across 10 hospitals over a one-year period. Patients were followed for 12 months. The primary endpoint was the composite of all-cause mortality or heart failure (HF) rehospitalization. Results: A total of 602 patients were included (37.0% women; mean age 72.6 ± 12.0 years), of whom 47.4% had heart failure with reduced left ventricular ejection fraction (HFrEF). During follow-up, 83 patients (13.8%) died and 105 (17.4%) were rehospitalized because of HF. Independent predictors of the primary endpoint were elevated admission N-terminal pro-B-type natriuretic peptide (NT-proBNP), atrial fibrillation (AF), chronic kidney disease (CKD), chronic obstructive pulmonary disease (COPD), previous HF, prior implantable cardioverter-defibrillator (ICD) implantation, and higher left ventricular ejection fraction (LVEF). Among patients with HFrEF, less comprehensive implementation of guideline-directed medical therapy (GDMT) at discharge was associated with significantly worse outcomes. Conclusions: In patients hospitalized with AHF, prognosis is primarily determined by comorbidity burden, admission NT-proBNP levels, previous HF, and LVEF. Among patients with HFrEF, more comprehensive implementation of GDMT at discharge was associated with improved clinical outcomes, supporting early optimization of evidence-based therapy during hospitalization.

  • Open Access

    A case report showing unusual atrial communication with severe regurgitation of multiple valves and pulmonary aneurysm: double atrial septum with persistent interatrial space

    by José Antonio Ortiz de Murua, Laura de la Fuente Blanco, Alberto Trigo-Bautista, María José Ruiz-Olgado

    We discuss an unusual association: double atrial septum, pulmonary artery aneurysm, and severe regurgitation of multiple valves. A 70-year-old man was admitted into the hospital because of progressive dyspnoea. Physical examination showed a blood pressure of 132/70 mmHg, a systolic murmur on the right upper sternal border, another systolic murmur at the apex, and a diastolic murmur at the lower left sternal border. Electrocardiogram revealed atrial fibrillation and complete left bundle branch block. Transthoracic echocardiography showed mitral prolapse, severe mitral, aortic, and pulmonary regurgitation, a 60 mm diameter pulmonary artery aneurysm, mild to moderate tricuspid regurgitation, and moderate pulmonary hypertension. Transoesophageal echocardiography also showed an unusual atrial communication consisting of a double atrial septum with a mid-line chamber between both atria. A cardiac magnetic resonance scan was performed and confirmed echocardiography findings and QP:QS ratio = 1.3. In our knowledge, this is the first case report with this association. We present the main clinical features of the double atrial septum with persistent interatrial space, its echocardiography anatomy, differential diagnosis, and embryology.

  • Open Access

    Giant pericardial cyst as the cause of syncope

    by María Elena Arnáiz-García, María José Ruiz-Olgado, José Luis Santos-Iglesias, José María González-Santos